ARCA biopharma, Inc.·4

Dec 19, 4:23 PM ET

Hove Anders D 4

4 · ARCA biopharma, Inc. · Filed Dec 19, 2022

Insider Transaction Report

Form 4
Period: 2022-12-15
Hove Anders D
10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-15+6,0006,000 total
    Exercise: $2.32Exp: 2032-12-15Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of December 15, 2022. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT